DEEP Measures launched the UCB-led Respiratory Mission pre-competitive effort to harmonise measurement definitions and device-agnostic Target Solution Profiles across indications including IPF, PPF, asthma, COPD, and non-CF bronchiectasis.

𝐃𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐢𝐬 𝐟𝐮𝐥𝐥 𝐨𝐟 𝐩𝐢𝐞𝐜𝐞𝐬. 𝐖𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐭𝐡𝐞 𝐩𝐮𝐳𝐳𝐥𝐞. Digital measures sit at the crossroads of technology, clinical science, regulatory strategy, and evidence generation. Most of the ecosystem focuses on one piece at a time. DEEP focuses on putting the whole puzzle together - for patients. 𝐖𝐡𝐚𝐭 𝐰𝐞 𝐝𝐨 DEEP is an ecosystem platform for digital measures in pharmaceutical drug development. We help sponsors define the right measure for the right context of use, validate it with regulator-ready evidence, deploy it inside clinical studies, and assemble the evidence packages that support regulatory and HTA acceptance. Our content is executable - not just published or catalogued, but structured to feed downstream systems and processes directly. High signal, low noise. Built to be used, not just read. 𝐖𝐡𝐞𝐫𝐞 𝐰𝐞 𝐬𝐢𝐭 DEEP was founded as a partner to a global pharma company and has spent the last several years working very closely with the relevant industry stakeholders including FDA, EMA and HTA bodies to deliver decision-grade digital measures. 𝐖𝐡𝐨 𝐰𝐞 𝐰𝐨𝐫𝐤 𝐰𝐢𝐭𝐡 Pharma sponsors at every stage of the digital-measures journey. Whether you need a single measurement definition validated, a study operations partner, or a complete evidence package - we connect the pieces. 𝐅𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬. 𝐓𝐡𝐚𝐭'𝐬 𝐭𝐡𝐞 𝐨𝐧𝐥𝐲 𝐭𝐡𝐢𝐧𝐠 𝐭𝐡𝐚𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬.